PROASSURANCE CORP SEC Filings

Magnetar Financial, Magnetar Capital Partners, Supernova Management and David J. Snyderman filed Amendment No. 1 to their Schedule 13D on ProAssurance Corporation to report that they now beneficially own 0 shares, or 0% of the common stock.

The change follows a merger completed on June 26, 2026, in which each ProAssurance share was cancelled and converted into the right to receive $25.00 in cash, without interest. In connection with this merger, the reporting persons’ 2,615,966 shares were cancelled for cash consideration at that price. The amendment is characterized as a final, exit filing, confirming that these Magnetar-affiliated investors are no longer 5% owners of ProAssurance stock.

ProAssurance Corp notifies removal of its Common Stock from listing and registration on the New York Stock Exchange LLC. The Exchange certifies it has complied with Rule 17 CFR 240.12d2-2 and the issuer has complied with Exchange rules governing voluntary withdrawal.

PROASSURANCE CORP director Maye Head Frei reported a disposition of shares in connection with the company’s merger. On June 26, 2026, 31,298 shares of Common Stock were disposed of to the issuer at $25.00 per share, leaving no shares reported as owned after the transaction.

This transaction reflects the closing of the merger in which a subsidiary of The Doctors Company combined with ProAssurance, with ProAssurance continuing as a wholly owned subsidiary. At the merger’s effective time, each outstanding common share, including deferred director shares, was cancelled and converted into the right to receive $25.00 in cash, subject to applicable withholding taxes.

PROASSURANCE CORP director Scott C. Syphax disposed of 25,184 shares of Common Stock at $25.00 per share as part of a cash merger. The shares were cancelled and converted into the right to receive the cash merger consideration, leaving him with zero directly owned shares after the transaction.

PROASSURANCE CORP director Bruce D. Angiolillo disposed of 35,652 shares of common stock in connection with the closing of the merger with The Doctors Company. Each share was cancelled at the effective time of the merger and converted into the right to receive $25.00 in cash, leaving him with no reported remaining shares.

PROASSURANCE CORP director Katisha Terrell Vance disposed of 34,159 shares of common stock in connection with the company’s merger. The shares were cancelled and converted into a right to receive $25.00 per share in cash at the merger’s effective time.

The transaction is reported as a disposition to the issuer tied to the completion of the merger with The Doctors Company, after which ProAssurance became a wholly owned subsidiary. Following this cash-out event, the filing shows Vance with 0 shares of ProAssurance common stock directly held.

ProAssurance Corporation director Staci Pierce reported a disposition of common stock tied to the company’s merger. On June 26, 2026, 10,621 shares of ProAssurance common stock were cancelled and converted into cash at $25.00 per share under the merger agreement with The Doctors Company.

This transaction was a disposition to the issuer as part of the merger closing, not an open-market trade. Following the cash-out, Pierce no longer holds any ProAssurance common stock.

PROASSURANCE CORP Chief Financial Officer Dana S. Hendricks reported dispositions of equity in connection with the company’s merger with The Doctors Company. On June 26, 2026, 45,392 shares of common stock were cancelled and converted into the right to receive $25.00 per share in cash under the merger terms.

The filing also shows dispositions of outstanding unvested restricted stock units representing 11,778, 7,686 and 23,720 shares of common stock, which automatically vested at the merger’s effective time and were cancelled for cash based on the same $25.00-per-share merger consideration. Following these merger-related transactions, the Form 4 reflects zero shares and RSUs held for this reporting person.